HealthCare Global Enterprises Past Earnings Performance
Past criteria checks 4/6
HealthCare Global Enterprises has been growing earnings at an average annual rate of 57%, while the Healthcare industry saw earnings growing at 22.7% annually. Revenues have been growing at an average rate of 16% per year. HealthCare Global Enterprises's return on equity is 6.8%, and it has net margins of 2.8%.
Key information
57.0%
Earnings growth rate
59.7%
EPS growth rate
Healthcare Industry Growth | 29.4% |
Revenue growth rate | 16.0% |
Return on equity | 6.8% |
Net Margin | 2.8% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Pinning Down HealthCare Global Enterprises Limited's (NSE:HCG) P/S Is Difficult Right Now
Dec 22HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned
Sep 19HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next
Feb 11We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation
Sep 14A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)
Sep 05HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price
May 17Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?
Jun 24Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings
Jun 03Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?
Dec 08What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?
Jun 25Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares
Mar 14The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On
Mar 03Revenue & Expenses Breakdown
How HealthCare Global Enterprises makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 20,436 | 570 | 624 | 0 |
30 Jun 24 | 19,770 | 526 | 0 | 0 |
31 Mar 24 | 19,121 | 482 | 624 | 0 |
31 Dec 23 | 18,592 | 353 | 765 | 0 |
30 Sep 23 | 18,140 | 371 | 765 | 0 |
30 Jun 23 | 17,471 | 309 | 0 | 0 |
31 Mar 23 | 16,944 | 293 | 765 | 0 |
31 Dec 22 | 16,174 | 270 | 274 | 0 |
30 Sep 22 | 15,507 | -264 | 274 | 0 |
30 Jun 22 | 14,827 | 694 | 0 | 0 |
31 Mar 22 | 13,978 | 537 | 274 | 0 |
31 Dec 21 | 13,312 | -544 | 190 | 0 |
30 Sep 21 | 12,472 | -379 | 190 | 0 |
30 Jun 21 | 11,431 | -1,633 | 0 | 0 |
31 Mar 21 | 10,134 | -1,935 | 190 | 0 |
31 Dec 20 | 9,858 | -1,349 | 289 | 0 |
30 Sep 20 | 9,897 | -1,284 | 289 | 0 |
30 Jun 20 | 10,202 | -1,284 | 0 | 0 |
31 Mar 20 | 10,956 | -1,067 | 289 | 0 |
31 Dec 19 | 10,832 | -718 | 685 | 0 |
30 Sep 19 | 10,541 | -552 | 685 | 0 |
30 Jun 19 | 10,210 | -394 | 0 | 0 |
31 Mar 19 | 9,787 | -248 | 685 | 0 |
31 Dec 18 | 9,430 | -135 | 623 | 0 |
30 Sep 18 | 9,004 | -41 | 623 | 0 |
30 Jun 18 | 8,661 | 124 | 623 | 0 |
31 Mar 18 | 8,307 | 205 | 623 | 0 |
31 Dec 17 | 7,909 | 257 | 440 | 0 |
30 Sep 17 | 7,608 | 278 | 440 | 0 |
30 Jun 17 | 7,237 | 219 | 0 | 0 |
31 Mar 17 | 7,001 | 230 | 440 | 0 |
31 Dec 16 | 6,705 | 208 | 298 | 0 |
30 Sep 16 | 6,392 | 133 | 298 | 0 |
30 Jun 16 | 6,081 | 67 | 298 | 0 |
31 Mar 16 | 5,842 | -178 | 320 | 0 |
31 Dec 15 | 5,611 | -33 | 68 | 0 |
30 Sep 15 | 5,494 | 9 | 579 | 110 |
30 Jun 15 | 5,323 | 9 | 217 | 0 |
31 Mar 15 | 5,194 | 8 | 299 | 0 |
31 Mar 14 | 4,513 | -356 | 254 | 0 |
Quality Earnings: HCG has high quality earnings.
Growing Profit Margin: HCG's current net profit margins (2.8%) are higher than last year (2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HCG has become profitable over the past 5 years, growing earnings by 57% per year.
Accelerating Growth: HCG's earnings growth over the past year (53.8%) is below its 5-year average (57% per year).
Earnings vs Industry: HCG earnings growth over the past year (53.8%) exceeded the Healthcare industry 29.6%.
Return on Equity
High ROE: HCG's Return on Equity (6.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 02:34 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HealthCare Global Enterprises Limited is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Candice Pereira | Anand Rathi Shares and Stock Brokers Limited |
Kripashankar Maurya | Choice Equity Broking Private Limited |
Deepika Murarka | Choice Equity Broking Private Limited |